A pan-cancer proteomic perspective on The Cancer Genome Atlas-Reference-Cited by-同舟云学术

A pan-cancer proteomic perspective on The Cancer Genome Atlas

Published:2014-05-29 Issue:1 Volume:5 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Akbani Rehan,Ng Patrick Kwok Shing,Werner Henrica M. J.,Shahmoradgoli Maria,Zhang Fan,Ju Zhenlin,Liu Wenbin,Yang Ji-Yeon,Yoshihara Kosuke,Li Jun,Ling Shiyun,Seviour Elena G.,Ram Prahlad T.,Minna John D.,Diao Lixia,Tong Pan,Heymach John V.,Hill Steven M.,Dondelinger Frank,Städler Nicolas,Byers Lauren A.,Meric-Bernstam Funda,Weinstein John N.,Broom Bradley M.,Verhaak Roeland G. W.,Liang Han,Mukherjee Sach,Lu Yiling,Mills Gordon B.

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/ncomms4887.pdf

Reference68 articles.

1. Myhre, S. et al. Influence of DNA copy number and mRNA levels on the expression of breast cancer related proteins. Mol. Oncol. 7, 704–718 (2013).

2. Park, E. S. et al. Integrative analysis of proteomic signatures, mutations, and drug responsiveness in the NCI 60 cancer cell line set. Mol. Cancer Ther. 9, 257–267 (2010).

3. Shankavaram, U. T. et al. Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study. Mol. Cancer Ther. 6, 820–832 (2007).

4. Cancer Genome Atlas N. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330–337 (2012).

5. Cancer Genome Atlas N. Comprehensive molecular portraits of human breast tumours. Nature 490, 61–70 (2012).

Cited by 471 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-cell chromatin accessibility reveals malignant regulatory programs in primary human cancers;Science;2024-09-06

2. A protein expression atlas on tissue samples and cell lines from cancer patients provides insights into tumor heterogeneity and dependencies;Nature Cancer;2024-09-03

3. Adaptive Responses to PARP Inhibition Predict Response to Olaparib and Durvalumab: Multi-omic Analysis of Serial Biopsies in the AMTEC Trial;2024-08-30

4. Whole genome and reverse protein phase array landscapes of patient derived osteosarcoma xenograft models;Scientific Reports;2024-08-27

5. Antitumor Effects and the Potential Mechanism of 10-HDA against SU-DHL-2 Cells;Pharmaceuticals;2024-08-20